Opportunity ID: 46674

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-09-147
Funding Opportunity Title: Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 08, 2009
Last Updated Date:
Original Closing Date for Applications: May 27, 2011
Current Closing Date for Applications: May 27, 2011
Archive Date: Jun 27, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
For profit organizations other than small businesses
State governments
City or township governments
County governments
Small businesses
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer. Applications that are exclusively focused on population studies and epidemiology will not be supported in connection with this FOA.

Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.This FOA runs in parallel with two other FOA of similar scientific scope: PA-08-243 and PA-08-244, which encourage applications under the R01 and R21 grant mechanisms, respectively.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-09-147.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-10T06:58:22-05:00

Share This Post, Choose Your Platform!

About the Author: